IMA vs L · rev $9.2M vs P/E 14, rev $18.45B
ImageneBio, Inc. (IMA) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
IMA currently screens at market cap $64.7M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the IMA and L stock pages for the full models.
Not investment advice.